These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24695513)

  • 21. Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference.
    McCullough PA; Haapio M; Mankad S; Zamperetti N; Massie B; Bellomo R; Berl T; Anker SD; Anand I; Aspromonte N; Bagshaw SM; Bobek I; Cruz DN; Daliento L; Davenport A; Hillege H; House AA; Katz N; Maisel A; Mebazaa A; Palazzuoli A; Ponikowski P; Ronco F; Shaw A; Sheinfeld G; Soni S; Vescovo G; Zanco P; Ronco C; Berl T;
    Nephrol Dial Transplant; 2010 Jun; 25(6):1777-84. PubMed ID: 20375030
    [No Abstract]   [Full Text] [Related]  

  • 22. Advancing nursing practice in rhythm recognition with an e-learning educational program.
    Forfa MJ
    Nephrol Nurs J; 2013; 40(2):159-63. PubMed ID: 23767340
    [No Abstract]   [Full Text] [Related]  

  • 23. Introduction: Kidney Disease and Cardiovascular Disease.
    Nangaku M
    Semin Nephrol; 2018 May; 38(3):207. PubMed ID: 29753397
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical practice. Stage IV chronic kidney disease.
    Abboud H; Henrich WL
    N Engl J Med; 2010 Jan; 362(1):56-65. PubMed ID: 20054047
    [No Abstract]   [Full Text] [Related]  

  • 25. COPD and associated comorbidities: a review of current diagnosis and treatment.
    Carlin BW
    Postgrad Med; 2012 Jul; 124(4):225-40. PubMed ID: 22913911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).
    Manns BJ; Hodsman A; Zimmerman DL; Mendelssohn DC; Soroka SD; Chan C; Jindal K; Klarenbach S
    Am J Kidney Dis; 2010 May; 55(5):800-12. PubMed ID: 20438984
    [No Abstract]   [Full Text] [Related]  

  • 27. Guidelines and medication compliance.
    Yokoyama K; Tanno Y; Ohkido I; Hosoya T
    Kidney Int; 2012 Mar; 81(6):595. PubMed ID: 22373704
    [No Abstract]   [Full Text] [Related]  

  • 28. Cutaneous and nail changes in patients of chronic kidney disease: observations in a tertiary care unit from South India.
    Koduru S; Delhi N; Parvathina SN; Siva Kumar V
    Hemodial Int; 2013 Jul; 17(3):468-70. PubMed ID: 23621562
    [No Abstract]   [Full Text] [Related]  

  • 29. Complications of progression of CKD.
    Yang M; Fox CH; Vassalotti J; Choi M
    Adv Chronic Kidney Dis; 2011 Nov; 18(6):400-5. PubMed ID: 22098657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outpatient management of chronic kidney disease: proteinuria, anemia and bone disease as therapeutic targets.
    Lam A; Shah S; Paparello J
    Dis Mon; 2010 Apr; 56(4):215-32. PubMed ID: 20350654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for the altered mineral metabolism of chronic kidney disease: implications for vascular calcification.
    Saab G; Whaley-Connell AT; Khanna R; Sowers JR
    Ther Adv Cardiovasc Dis; 2007 Dec; 1(2):107-12. PubMed ID: 19124399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is lipid management effective for all stages of CKD?
    Ku E; Campese V
    Blood Purif; 2013; 35(1-3):26-30. PubMed ID: 23343543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular complications of chronic kidney disease.
    Ross L; Banerjee D
    Int J Clin Pract; 2013 Jan; 67(1):4-5. PubMed ID: 23241045
    [No Abstract]   [Full Text] [Related]  

  • 34. Chronic kidney disease: the forgotten cardiovascular risk factor.
    Barrios V; Escobar C; Echarri R
    Int J Clin Pract; 2009 Jun; 63(6):964-5. PubMed ID: 19490206
    [No Abstract]   [Full Text] [Related]  

  • 35. The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors.
    Sera N; Hida A; Imaizumi M; Nakashima E; Akahoshi M
    Radiat Res; 2013 Jan; 179(1):46-52. PubMed ID: 23148507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial dysfunction in chronic kidney disease: determinant of susceptibility to end-organ damage and therapeutic response.
    Ochodnicky P; Vettoretti S; Henning RH; Buikema H; Van Dokkum RP; de Zeeuw D
    J Nephrol; 2006; 19(3):246-58. PubMed ID: 16874683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dentist-nephrologist symbiosis in the dental management of chronic kidney disease patient.
    Chidambaram R
    J Coll Physicians Surg Pak; 2014 Dec; 24(12):955. PubMed ID: 25523738
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertension and cardiovascular risk in chronic kidney disease.
    Luño J; Iturbe BR; Zoccali C
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv1. PubMed ID: 23258803
    [No Abstract]   [Full Text] [Related]  

  • 39. Obstructive sleep apnoea: clinical signs, diagnosis and treatment.
    Kuhlmann U; Bormann FG; Becker HF
    Nephrol Dial Transplant; 2009 Jan; 24(1):8-14. PubMed ID: 18786973
    [No Abstract]   [Full Text] [Related]  

  • 40. The Wellpoint/Anthem approach to chronic kidney disease.
    Howard RL
    Nephrol News Issues; 2005 Nov; 19(12):49-51, 88. PubMed ID: 16315545
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.